Andreas Jeromin

Andreas Jeromin is the Chief Scientific Officer for assay development, business development, and regulatory guidance. Dr. Jeromin was Director of Business Development and Assay Development for Banyan Biomarkers for the past three years and Chief Scientific Officer of NextGen Sciences, Inc. Dr. Jeromin participates on multiple national and international committees for the validation of biomarkers for Alzheimer’s disease and Parkinson’s disease and has co-authored more than 150 publications and is one of the international leaders in CNS biomarkers.